This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Cochrane Handbook for Systematic Reviews of Interventions | |
|---|---|
| Name | Cochrane Handbook for Systematic Reviews of Interventions |
| Author | Cochrane Collaboration |
| Country | United Kingdom |
| Language | English |
| Subject | Systematic reviews, evidence synthesis, clinical trials |
| Publisher | Cochrane |
| Release date | 1994– |
| Media type | Print, online |
Cochrane Handbook for Systematic Reviews of Interventions The Cochrane Handbook for Systematic Reviews of Interventions is a methodological manual used to design, conduct, and report systematic reviews of healthcare interventions, guiding authors within the Cochrane Collaboration, the World Health Organization, the National Institute for Health and Care Excellence, and related agencies. It serves as a reference across clinical guideline development at institutions such as the United States Food and Drug Administration, the European Medicines Agency, and academic centers including the Johns Hopkins University, Harvard University, and the University of Oxford.
The Handbook sets standards for identifying randomized controlled trials and observational studies, integrating guidance adopted by entities like the World Health Organization, the United Kingdom National Health Service, the Centers for Disease Control and Prevention, and the Agency for Healthcare Research and Quality. It informs methodology applied by research groups at the University of Cambridge, McMaster University, the London School of Hygiene & Tropical Medicine, and the Institute for Clinical Evaluative Sciences. Authors use it alongside reporting frameworks such as CONSORT, PRISMA, and GRADE when producing systematic reviews for journals like The Lancet, The BMJ, JAMA, and Annals of Internal Medicine.
The Handbook originated from practices developed within the Cochrane Collaboration during the 1990s, paralleling efforts by figures and organizations like Archie Cochrane, the British Medical Journal, the National Library of Medicine, and the Cochrane Editorial Unit. Its evolution intersected with initiatives at the World Health Organization, the International Committee of Medical Journal Editors, the Centre for Reviews and Dissemination at the University of York, and the Nordic Cochrane Centre. Updates reflected methodological advances discussed at conferences such as the Annual Cochrane Colloquium, meetings of the Campbell Collaboration, and symposia hosted by the Royal Society and the Wellcome Trust.
The Handbook is organized into chapters covering protocol development, searching bibliographic databases, selection criteria, data extraction, risk of bias assessment, meta-analysis, and interpretation, providing workflows used by trialists and methodologists at institutions like King's College London, Imperial College London, and Stanford University. It cross-references tools and standards from entities such as the Cochrane Risk of Bias Group, the GRADE Working Group, the International Prospective Register of Systematic Reviews, and the EQUATOR Network. Practical chapters outline collaboration workflows familiar to contributors affiliated with the European Commission, the World Bank, and the Bill & Melinda Gates Foundation.
Guidance addresses randomized trials, cluster trials, crossover trials, quasi-experimental designs, and non-randomized studies, with methods comparable to those endorsed by the Food and Drug Administration, the European Medicines Agency, and Health Technology Assessment agencies. Core topics include search strategy design using resources like PubMed, Embase, CENTRAL, and ClinicalTrials.gov; selection processes paralleling practices at Cochrane review groups; statistical synthesis employing meta-analytic techniques used in papers from Nature, Science, and PLOS Medicine; and certainty assessment via GRADE as utilized by WHO guideline panels and NICE committees. The Handbook also covers subgroup analyses, network meta-analysis methods applied in research from the University of Toronto, sensitivity analyses used in trials overseen by the National Institutes of Health, and reporting consistent with PRISMA guidance endorsed by journals such as The New England Journal of Medicine and Cell Press.
Major iterations have been issued to incorporate methodological innovations discussed at workshops hosted by the Wellcome Trust, the Royal Society, and the Gates Foundation, with editorial contributions from experts affiliated with McMaster University, the University of Oxford, and the Cochrane Methods Groups. Revisions respond to developments in trial registration promoted by the International Committee of Medical Journal Editors, data sharing policies influenced by the European Commission and the US National Academies, and statistical advances reported in outlets including Biometrics and Statistical Methods in Medical Research.
The Handbook underpins systematic reviews used in clinical guidelines by bodies such as the National Institute for Health and Care Excellence, the World Health Organization, the American College of Physicians, and specialist societies like the American Heart Association and the American Diabetes Association. It informs health policy appraisals conducted by the Organisation for Economic Co-operation and Development, Health Canada, and state health departments, and is cited in evidence syntheses published in high-impact journals including The Lancet, BMJ, JAMA, and PLOS Medicine. Academic courses at institutions such as Harvard Medical School, Yale School of Medicine, and the University of Edinburgh incorporate its methods, and NGOs like Médecins Sans Frontières and the Red Cross reference its guidance when assessing intervention effectiveness.
Critiques note that the Handbook's emphasis on randomized evidence echoes debates involving the Cochrane Collaboration, the GRADE Working Group, and regulators like the FDA and EMA about applicability to real-world evidence, observational studies, and complex interventions evaluated by groups such as the Campbell Collaboration. Methodologists from institutions including the London School of Hygiene & Tropical Medicine and the University of Bristol have argued for greater clarity on equity considerations and implementation science, and commentators in The BMJ, The Lancet, and Health Affairs have discussed challenges in applying Handbook methods to rapid reviews commissioned by agencies like WHO, NICE, and state public health offices.
Category:Systematic reviews